Survival rates among COVID-19 patients treated with high flow nasal oxygen therapy with a do-not-intubate-order: an observational study

I. Smesseim (Amsterdam, Netherlands), B. Atasever (Haarlem, Netherlands), L. Hessels (Alkmaar, Netherlands), D. Korevaar (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), B. Goorhuis (Amsterdam, Netherlands), E. Nossent (Amsterdam, Netherlands), K. Mooij-Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands)

Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Session: Acute non-invasive respiratory therapies in COVID-19 and beyond
Session type: E-poster
Number: 1762

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Smesseim (Amsterdam, Netherlands), B. Atasever (Haarlem, Netherlands), L. Hessels (Alkmaar, Netherlands), D. Korevaar (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), B. Goorhuis (Amsterdam, Netherlands), E. Nossent (Amsterdam, Netherlands), K. Mooij-Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands). Survival rates among COVID-19 patients treated with high flow nasal oxygen therapy with a do-not-intubate-order: an observational study. 1762

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High Flow nasal OXygen therapy in high risk patients of hypoxia undergoing diagnostic BRONCHOscopy (HiFOXy-BRONCHO):a prospective, randomized, controlled study
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018

Electromyographic swallowing study during high flow oxygen therapy compared with low flow oxygen therapy in post-extubated patients
Source: International Congress 2019 – Recent developments in intensive care unit medicine
Year: 2019


COPD patients’ experience of long-term domestic oxygen-enriched nasal high flow treatment: A qualitative study.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020


Survival in COPD patients under long-term oxygen therapy
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019

Survival in patients on long-term oxygen therapy (LTOT)
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Long-term oxygen therapy: compliance of patients
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Survival after intensive care for COPD exacerbation in patients with and without long-term oxygen therapy: a nationwide cohort study
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019

Relative survival of patients with COPD on long-term oxygen therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 275s
Year: 2001

The association of the oxygen saturation level at the time of hospitalization with comorbidities and subsequent changes in blood biomarkers in patients with COVID-19 in Russia: observational study results.
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


First and second waves results of COVID-19 patients treated with non-invasive respiratory therapies outside the ICU: unicentric, observational study
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021


Transtracheal oxygen therapy as an effective treatment in patients suffering from severe hypoxemia and with high flow oxygen requirement: Description of two cases
Source: Annual Congress 2011 - A little bit of everything: interventional pneumology
Year: 2011


Effects of N-acetylcysteine treatment during long-term oxygen therapy (LTOT) in COPD patients. An open parallel-group study
Source: Eur Respir J 2001; 18: Suppl. 33, 58s
Year: 2001

Survival and quality of life of patients treated by long term noninvasive ventilation (NIV). Results from a prospective cohort study.
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017


Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy.
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


Comparison of continuous flow versus demand oxygen delivery systems in COPD patients: a systematic review and meta-analysis
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018



Predictors of success in COPD exacerbation treated with non-invasive mechanical ventilation (NIMV): a 5-year prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 278s
Year: 2002

Long-term nasal high flow treatment with oxygen in COPD - exacerbations, admissions and mortality
Source: International Congress 2017 – Best abstracts in physical activity and management of COPD
Year: 2017


High-flow oxygen therapy vs non invasive ventilation: a prospective randomized cross-over physiological study of alveolar recruitment in acute respiratory failure
Source: International Congress 2019 – Current trends in noninvasive ventilation for acute respiratory failure
Year: 2019



A retrospective study of the use of ROX index to predict failure in patients receiving CPAP for COVID-19
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021


Early non-invasive ventilation versus conventional oxygen therapy in immunocompromised patients with respiratory failure: a meta-analysis
Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation
Year: 2017